Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01372267 · ClinicalTrials.gov registry record · NA

Psychosocial Pain Management During Addictions Treatment to Improve Outcomes

A NA study of Pain, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
510
Enrollment target
1
Study location

NCT01372267: Completed NA study of Pain, sponsored by University of Michigan.

NCT01372267 is a NA study of Pain that has completed, run by University of Michigan. The registered enrollment target is 510 participants, above the 303-participant average among 374 other Pain trials with a reported enrollment target (68% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01372267, a NA study of Pain, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
510 participants
Enrollment target
1
Study location

Study Summary

The present intervention is a Stage II randomized controlled efficacy trial of a group-based intervention that integrates Cognitive Behavioral Therapy (CBT) for pain and substance use disorders (SUDs) compared to a Supportive Psychoeducation Control (SPC) group in a sample of patients receiving residential SUD treatment with co-occurring chronic pain. A total of 452 patients (226 male and 226 female) with current pain rated as moderately severe or greater and comorbid drug or alcohol use disorder(s) will be recruited from a large residential SUD treatment program. These participants will be randomly assigned to either a 4-week (8-session) group of integrated CBT for pain and SUDs or a 4-week (8-session) SPC group. All participants will be re-assessed immediately post-treatment (1 month) and again at 3, 6, and 12 months post-intervention. Through this randomized controlled trial, the investigators hope to gain insight on how to improved treatment of pain in those with SUDs that could result in enhanced quality of life and improved pain-related, substance use, and other health outcomes. Evaluating a psychosocial intervention for pain and substance use that can be delivered during a SUD treatment episode would significantly extend available treatment options for the large numbers of patients with pain seen by SUD treatment providers. The investigators also hope to determine the efficacy of an evidence-based psychosocial pain management approach in men and women from a large and diverse residential addiction treatment program.

Primary Outcome

For each follow-up time point, we will subtract the baseline value to obtain a change score

Conditions Studied

Interventions

  • BEHAVIORAL Psychoeducation for substance abuse
  • BEHAVIORAL CBT for pain in Substance abuse

Study Locations (1)

Michigan

  • Community Programs, INC. - Waterford

Trial Details

FieldValue
Enrollment Target 510 participants
Start Date 2011-10
Est. Completion 2017-04
Phase NA
University of Michigan

1,327 total trials

What the finished NCT01372267 record still lists

NCT01372267 is an interventional study that assigns participants to a tested intervention. The registered 510 participants enrollment target is mid-sized for trials with a published cap, above the 303-participant average among 374 other Pain trials with a reported enrollment target (68% higher).

The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Psychoeducation for substance abuse is the first listed.

NCT01372267 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT01372267 about?

NCT01372267 is a clinical study titled "Psychosocial Pain Management During Addictions Treatment to Improve Outcomes". The present intervention is a Stage II randomized controlled efficacy trial of a group-based intervention that integrates Cognitive Behavioral Therapy (CBT) for pain and substance use disorders (SUDs) compared to a Supportive Psychoeducation Control (SPC) group in a sample of patients receiving resi...

What is the current status of trial NCT01372267?

This trial is currently completed. It is a NA study. The enrollment target is 510 participants. The study started on 2011-10. Estimated completion is 2017-04.

What conditions does trial NCT01372267 study?

This clinical trial studies the following conditions: Pain.

What interventions are being tested in trial NCT01372267?

The interventions under investigation include: Psychoeducation for substance abuse (BEHAVIORAL), CBT for pain in Substance abuse (BEHAVIORAL).

Who is sponsoring clinical trial NCT01372267?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01372267 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01372267's enrollment target sits among peer trials

510 29th of 374 higher than 346 of 374 other Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03922542 · 510 participants · Phase 2

    Comparison of Standard vs. Accelerated Corneal Crosslinking

  • NCT04634552 · 510 participants · Phase 2

    A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma

  • NCT05164744 · 510 participants

    Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors

  • NCT05451004 · 510 participants · Phase 3

    SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01372267, the US trial registry maintained by the National Library of Medicine. NCT01372267 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.